IMCAS World Congress 2024
Program

Objectives: To give an overview on state of the art and future projects and challanges of the most commonly used toxins in Europe and the US

Introduction: More an more toxins are comming to the market. This might be specifically for novices confusing. Together with the industry we would give an overview on the present toxins on the Europen and US market.

Materials / method: Based on the answers of the companies on a pre-meeting questionnaire a presentation was developed that will be presented by the representatives of the companies and moderated by the two chairs.

Results: The following questions will be discussed: (1) Characteristics of the toxins including differences to the other toxins (2) the evidence based on clinical and preclinical trials (3) new aspects (4) toxin fatigue (5) the longterm efficacy

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability